words lines 0 60 0 20 top 50% bottom top 1 0 0 .22 back 1 0 .001 1 .1 1.5 none top bottom center center true 1 none top top center top true 0 200 .001 none
top bottom top center true 1 none top bottom bottom bottom true 1 none

Acquisition International Magazine’s M&A Award 2022 for Best Cell & Gene Therapy Acquisition 2022

Dec 27, 2022

Juniper Biologics

Author

We’re proud to announce that we’ve won Acquisition International Magazine’s M&A Award 2022 for Best Cell & Gene Therapy Acquisition 2022, in recognition of our licensing deal for TG-C LD ! This acquisition was our first step in ensuring patients suffering from osteoarthritis receive the treatment they need and have the quality of life they deserve. 

Juniper Biologics (2022 Winner: M&A Awards) – Acquisition International (acquisition-international.com)

CARIS MEA
Juniper Biologics Expands Distribution Rights for Caris Life Sciences’ Molecular Profiling in the Middle East and Africa
Pharmaceutical Company of the Year
Juniper Biologics Named “Pharmaceutical Company of the Year” at Corporate LiveWire Global Awards USA – English 
APAC Insider
Advancing Healthcare Innovation: Juniper Biologics Recognized as the Best Novel Therapy R&D and Commercialization Company 2024 by APAC Insider
Follow us on Facebook